Biotech Boulevard
Startups and Spinouts
GEN's Biotech Boulevard highlights new entrepreneurial biotech firms based all over the globe. These unique companies are developing breakthrough products that will expand and enhance the biotech industry.
Discover, invest, and collaborate with these industry leaders of tomorrow.
Explore Biotech Boulevard. It's paved with opportunities!
GEN's Biotech Boulevard
All  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z   0  1  2  3  4  5  6  7  8  9   
  • Telormedix

    Telormedix is a biopharmaceutical company focused on targeted immunity and the role of the innate immune system in treating cancer and autoimmune diseases. The company’s lead product, TMX-101, proved to have a good safety profile in humans during the first stage of a Phase I/II clinical trial for the localised treatment of Non-Muscle Invasive Bladder Cancer (NMIBC).

  • Tioga Pharmaceuticals

    Tioga Pharmaceuticals is a virtual company developing the Phase III product candidate asimadoline for the treatment of diarrhea-predominant irritable bowel syndrome.

  • Tunitas Therapeutics

    Tunitas Therapeutics is a privately held biopharmaceutical company that is developing targeted protein therapeutics. Tunitas’ proteins are capable of altering the natural course of such allergic diseases as food allergies, asthma, rhinitis and atopic dermatitis. The company’s therapeutic approach offers the potential for long-lasting treatments. Tunitas is also developing a next-generation immunotherapy platform of fusion proteins which offer the prospect of long-term relief for specific allergic diseases.

© 2012 Genetic Engineering & Biotechnology News. All Rights Reserved.
Back to